249 related articles for article (PubMed ID: 12826700)
1. Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone.
Bouloux PM; Nieschlag E; Burger HG; Skakkebaek NE; Wu FC; Handelsman DJ; Baker GH; Ochsenkuehn R; Syska A; McLachlan RI; Giwercman A; Conway AJ; Turner L; van Kuijk JH; Voortman G
J Androl; 2003; 24(4):604-11. PubMed ID: 12826700
[TBL] [Abstract][Full Text] [Related]
2. An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism.
Nieschlag E; Bouloux PG; Stegmann BJ; Shankar RR; Guan Y; Tzontcheva A; McCrary Sisk C; Behre HM
Reprod Biol Endocrinol; 2017 Mar; 15(1):17. PubMed ID: 28270212
[TBL] [Abstract][Full Text] [Related]
3. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin.
Warne DW; Decosterd G; Okada H; Yano Y; Koide N; Howles CM
Fertil Steril; 2009 Aug; 92(2):594-604. PubMed ID: 18930225
[TBL] [Abstract][Full Text] [Related]
4. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
Liu L; Banks SM; Barnes KM; Sherins RJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism.
Matsumoto AM; Snyder PJ; Bhasin S; Martin K; Weber T; Winters S; Spratt D; Brentzel J; O'Dea L
Fertil Steril; 2009 Sep; 92(3):979-990. PubMed ID: 18930190
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism.
Burgués S; Calderón MD
Hum Reprod; 1997 May; 12(5):980-6. PubMed ID: 9194651
[TBL] [Abstract][Full Text] [Related]
7. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis.
Zacharin M; Sabin MA; Nair VV; Dabadghao P
Fertil Steril; 2012 Oct; 98(4):836-42. PubMed ID: 22763096
[TBL] [Abstract][Full Text] [Related]
8. Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man.
Matsumoto AM; Karpas AE; Bremner WJ
J Clin Endocrinol Metab; 1986 Jun; 62(6):1184-92. PubMed ID: 3084535
[TBL] [Abstract][Full Text] [Related]
9. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism.
Schaison G; Young J; Pholsena M; Nahoul K; Couzinet B
J Clin Endocrinol Metab; 1993 Dec; 77(6):1545-9. PubMed ID: 8263139
[TBL] [Abstract][Full Text] [Related]
10. Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone.
Depenbusch M; von Eckardstein S; Simoni M; Nieschlag E
Eur J Endocrinol; 2002 Nov; 147(5):617-24. PubMed ID: 12444893
[TBL] [Abstract][Full Text] [Related]
11. hCG-induced maturation of the seminiferous epithelium in hypogonadotropic men.
D'Agata R; Heindel JJ; Vicari E; Aliffi A; Gulizia S; Polosa P
Horm Res; 1984; 19(1):23-32. PubMed ID: 6420302
[TBL] [Abstract][Full Text] [Related]
12. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
Mao JF; Liu ZX; Nie M; Wang X; Xu HL; Huang BK; Zheng JJ; Min L; Kaiser UB; Wu XY
Asian J Androl; 2017; 19(6):680-685. PubMed ID: 28051040
[TBL] [Abstract][Full Text] [Related]
13. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases.
Büchter D; Behre HM; Kliesch S; Nieschlag E
Eur J Endocrinol; 1998 Sep; 139(3):298-303. PubMed ID: 9758439
[TBL] [Abstract][Full Text] [Related]
14. Human chorionic gonadotrophin treatment prior to microdissection testicular sperm extraction in non-obstructive azoospermia.
Shiraishi K; Ohmi C; Shimabukuro T; Matsuyama H
Hum Reprod; 2012 Feb; 27(2):331-9. PubMed ID: 22128297
[TBL] [Abstract][Full Text] [Related]
15. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
Ley SB; Leonard JM
J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
[TBL] [Abstract][Full Text] [Related]
16. Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study.
Chen YW; Niu YH; Xu H; Wang DQ; Jiang HY; Pokhrel G; Wang T; Wang SG; Liu JH
Asian J Androl; 2019; 21(4):413-418. PubMed ID: 30604694
[TBL] [Abstract][Full Text] [Related]
17. Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism.
Sinisi AA; Esposito D; Maione L; Quinto MC; Visconti D; De Bellis A; Bellastella A; Conzo G; Bellastella G
Hum Reprod; 2008 May; 23(5):1029-34. PubMed ID: 18343809
[TBL] [Abstract][Full Text] [Related]
18. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence.
Rohayem J; Hauffa BP; Zacharin M; Kliesch S; Zitzmann M;
Clin Endocrinol (Oxf); 2017 Jan; 86(1):75-87. PubMed ID: 27467188
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of recombinant human follicle stimulating hormone at low doses in inducing spermatogenesis and fertility in hypogonadotropic hypogonadism.
Sinisi AA; Esposito D; Bellastella G; Maione L; Palumbo V; Gandini L; Lombardo F; De Bellis A; Lenzi A; Bellastella A
J Endocrinol Invest; 2010 Oct; 33(9):618-23. PubMed ID: 20436264
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male.
Kliesch S; Behre HM; Nieschlag E
Fertil Steril; 1995 Jun; 63(6):1326-8. PubMed ID: 7750608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
